In addition, TGF-β1 signaling negatively influences the tumor immune microenvironment by suppressing CD8+ T and natural killer (NK) cells, and by promoting regulatory T-cell (T-reg) proliferation (28, 55, 56). Here, CD8A is linked to neoplasm.